Vaccines Archives

mRNA DNA race Covid 19 vaccine BioNTech Pfizer

News and Trends 22 Dec 2020

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

BioNTech and Pfizer’s Covid-19 vaccine, made from messenger RNA, has become the first of its kind to be approved by the EMA. The EMA has granted conditional approval to Comirnaty, a vaccine against Covid-19 developed by BioNTech and Pfizer. The approval comes weeks after the UK became the first country in the world to approve […]

December 22, 2020 - 5 minutesmins - By Jonathan Smith

News and Trends 26 Nov 2020

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70% efficacy in phase III interim data. While less effective on paper, it could prove cheaper and easier to distribute than its most advanced competitors. Scientists and politicians heartily received the announcement of promising interim clinical trial results from the Covid-19 […]

November 26, 2020 - 4 minutesmins - By Kostas Vavitsas

News and Trends 29 Oct 2020

Universal Flu Vaccines Yield Second Clinical Failure This Year

In a blow to hopes for better protection from seasonal flu, last week’s phase III failure of BiondVax’s universal flu vaccine follows the phase II flop of Vaccitech’s flu vaccine in January. Last week proved a major setback for the Israeli biotech BiondVax. The company’s vaccine — designed to protect against multiple strains of flu […]

October 29, 2020 - 5 minutesmins - By Jonathan Smith

cancer vaccine virus ervaxx cell therapy

News and Trends 17 Aug 2020

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

The share price of CureVac has skyrocketed almost fivefold after the Covid-19 vaccine developer priced a Nasdaq IPO at €180M ($213M). The excitement around messenger RNA (mRNA) vaccines against Covid-19 could also benefit other players in mRNA therapeutics. CureVac’s IPO was priced at €14 ($16) per share, giving the German company a valuation of around […]

August 17, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 8 Jul 2020

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Osivax, a Lyon-based biotechnology company, secured €17.5M from the European Innovation Council and €15.1M from Bpifrance. The funding will be used to develop vaccines that protect from all current – and even future – flu and coronavirus outbreaks. Most current vaccines have a specific target protein they work against. They train the immune system to […]

July 8, 2020 - 3 minutesmins - By Kostas Vavitsas

News and Trends 18 Jun 2020

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

Belgian biotech eTheRNA has secured €34M in Series B funding to progress to the clinic its Covid-19 vaccine candidate and cancer immunotherapies made from messenger RNA. The company’s five existing investors contributed to the round, including Dutch VC firm LSP, and the Boehringer Ingelheim Venture Fund, based in Germany. Four new investors also contributed — […]

June 18, 2020 - 3 minutesmins - By Helen Albert

In Depth 18 May 2020

Will Covid-19 Change the Face of Vaccine Development?

The unprecedented scale of the current Covid-19 pandemic has led to a vaccine ‘race’ the like of which has never been seen before. This may change the face of vaccine development forever. Since the English physician Edward Jenner invented the first smallpox vaccine in 1796, vaccines have resulted in dramatic reductions in deaths from previously […]

May 18, 2020 - 13 minutesmins - By Helen Albert

News and Trends 24 Apr 2020

First Volunteers Dosed with European Coronavirus Vaccine

The first European vaccine for coronavirus disease to enter clinical trials has been administered to UK volunteers in a project led by the University of Oxford. One volunteer was injected with the coronavirus vaccine and another with a control vaccine yesterday in a phase I trial that aims to recruit over 1,000 participants. The trial […]

April 24, 2020 - 3 minutesmins - By Jonathan Smith

valo therapeutics oxford finland cancer immunotherapy

Startup Scout 27 Mar 2020

This Startup is Making a Cancer Vaccine out of Viruses

Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine based on a virus designed to kill tumors. Mission: To combine two different immunotherapy techniques — oncolytic viruses and cancer vaccines — into one treatment for solid tumors. Immunotherapy has transformed the cancer treatment landscape, offering therapies such as checkpoint […]

March 27, 2020 - 4 minutesmins - By Jonathan Smith

moderna biontech personalized cancer vaccine

News and Trends 24 Mar 2020

Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II

The UK immunotherapy company Vaccitech has announced promising initial results from a phase IIa trial of a therapeutic vaccine that could offer a new way to treat advanced prostate cancer. In the open-label trial, the University of Oxford spin-off enrolled 23 patients with advanced castration-resistant prostate cancer. The patients received the company’s viral vector vaccine […]

March 24, 2020 - 2 minutesmins - By Anita Chakraverty

News and Trends 3 Feb 2020

CureVac Bids to Develop First mRNA Coronavirus Vaccine

RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global partnership to develop an mRNA vaccine against the new coronavirus strain from China. The agreement follows on from an existing collaboration launched in 2019, when the Coalition for Epidemic Preparedness Innovations, or CEPI, granted CureVac €30M to develop facilities that […]

February 3, 2020 - 2 minutesmins - By Jonathan Smith

Startup Scout 24 Jan 2020

This Company is Using Moths to Make Vaccines

Madrid-based company Algenex is using moths as natural bioreactors to improve the speed and scalability of making proteins used in vaccines and diagnostics. Mission: To harness nature for simple, scalable, and cost-efficient recombinant protein manufacture. While many proteins are manufactured using bacteria, some are made using insect cells because these cells are sometimes better […]

January 24, 2020 - 4 minutesmins - By External Contributor

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Vaccines

EMA Greenlights BioNTech and Pfizer mRNA Vaccine for Covid-19

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

Universal Flu Vaccines Yield Second Clinical Failure This Year

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

Osivax Raises €32M to Develop Universal Coronavirus and Influenza Vaccines

Belgian mRNA Vaccine for Covid-19 Receives €34M Series B Boost

Will Covid-19 Change the Face of Vaccine Development?

First Volunteers Dosed with European Coronavirus Vaccine

This Startup is Making a Cancer Vaccine out of Viruses

Vaccitech’s Prostate Cancer Vaccine Shows Promise in Phase II

CureVac Bids to Develop First mRNA Coronavirus Vaccine

This Company is Using Moths to Make Vaccines

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!